No trading action warranted, this is a standard annual meeting with uncontested board elections and routine auditor ratification. Monitor for any unexpected voting outcomes, though none are anticipated given management's unified recommendation.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 2 $21.21entry
- T+1 · 8mo ago +1.79%α +1.32% · $21.59
- T+5 · 7mo ago +5.47%α +1.85% · $22.37
- T+20 · 7mo ago +17.16%α +7.29% · $24.85
- T+60 · 5mo ago +21.31%α +7.15% · $25.73
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Privia Health Group is holding its 2026 annual shareholder meeting to vote on the re-election of three Class I directors, advisory approval of executive compensation, and ratification of PricewaterhouseCoopers as auditor. The filing is a routine proxy statement with no contested proposals or activist involvement.
Key Financial Metrics
Key Facts
- Annual meeting scheduled for May 20, 2026
- Proposals include election of three directors: Nancy Cocozza, David King, and Francis Soistman
- Advisory vote on executive compensation
- Ratification of PricewaterhouseCoopers as independent auditor
- No dissident or activist involvement in the proxy materials
Financial Impact
No immediate financial impact, routine governance matters
Risk Factors
- Low risk of shareholder opposition to executive compensation, though recent insider selling could raise governance concerns
- No material governance risks apparent from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-139002 |
| Document: 0001193125-26-139002-index-headers.html | 0001193125-26-139002 |
| Document: 0001193125-26-139002-index.html | 0001193125-26-139002 |
| Document: 0001193125-26-139002.txt | 0001193125-26-139002 |
Track record
20 reports on PRVA
4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +10.73% at T+60 after the Mar 9, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 5, 202611d ago 8-K Mixed 6/10 No price data
- Nov 5, 202611d ago Press Release Bearish 5/10 Entry $23.94 to $23.67 Now $25.26 −5.51% ▲ +1.13% +4.42% vs SPY
- Nov 2, 202614d ago Press Release Neutral 3/10 Entry $21.28 to $24.54 Now $25.26 +18.70% ▲ +15.32% +15.24% vs SPY
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $21.48 to $24.42 Now $25.26 +17.60% ▲ +13.69% +16.39% vs SPY
- Oct 7, 20265w ago SC 13G/A Neutral 3/10 Entry $20.30 to $21.67 Now $25.26 +24.43% ▲ +6.75% +7.73% vs SPY
- Jul 13, 202618w ago Insider Cluster Neutral 3/10 Entry $28.03 to $26.26 Now $25.26 −9.88% ▼ −6.31% −5.02% vs SPY
- Jul 9, 202618w ago Insider Cluster Neutral 3/10 Entry $27.49 to $26.90 Now $25.26 −8.11% ▼ −2.15% −0.60% vs SPY
- Jul 7, 202618w ago Insider Cluster Neutral 3/10 Entry $27.21 to $28.10 Now $25.26 −7.17% ▲ +3.27% +2.01% vs SPY
- Jul 7, 202618w ago Press Release Neutral 1/10 Entry $27.23 to $28.03 Now $25.26 −7.23% ▲ +2.94% +2.39% vs SPY
- Jul 2, 202619w ago Insider Cluster Neutral 3/10 Entry $27.36 to $27.77 Now $25.26 −7.68% ▲ +1.50% +0.57% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers